CLINICAL_TRIALS
trial_result
· 2020-02-19
Clinical Trial Update: Safety and Efficacy of Nemolizumab in PN [Phase 2]
Summary
Phase 2 clinical trial update assessing safety and efficacy of nemolizumab in prurigo nodularis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Galderma R&D | Conditions: Prurigo Nodularis | Phase 2 | Status: COMPLETED | Results posted: 2020-02-19